SHOP.AGUARDIENTECLOTHING.COM Books > Cardiovascular > The Year in Interventional Cardiology 2002 by H.D. White, Pim J. de Feyter, Bernhard Meier, Antonio

The Year in Interventional Cardiology 2002 by H.D. White, Pim J. de Feyter, Bernhard Meier, Antonio

By H.D. White, Pim J. de Feyter, Bernhard Meier, Antonio Colombo, A.P. Banning, R. Schrader

The yr in Interventional Cardiology 2002 presents an outline of the present literature within the box and identifies the papers released some time past eighteen months that experience in all probability replaced perform, or that expect possible destiny advancements. It supplies the reader an up to date precis of contemporary learn findings, and their implications for medical administration. It offers a hugely centred evaluation of the present literature, compiled by way of knowledgeable group from one of many prime facilities within the box. those good points make it a pragmatic and obtainable source that every one medical professionals will locate important of their day-by-day perform.

Show description

Read Online or Download The Year in Interventional Cardiology 2002 PDF

Similar cardiovascular books

Clinical Challenges in Hypertension II

This identify provides an cutting edge new method of healing decision-making and gives solutions to a variety of questions that the busy clinician faces each day. a sequence of discussions, chosen through professional members, all across the world recognized professionals of their fields, supply their very own options for coping with tough difficulties and supply insights into the worth or differently of assorted therapy offerings in response to their very own adventure and the on hand proof.

Cardiovascular Magnetic Resonance: Established and Emerging Applications

An authoritative, up to date source at the usually intimidating technical enigma of CMR, Cardiovascular Magnetic Resonance: tested and rising functions consolidates a large and turning out to be physique of knowledge right into a unmarried balanced resource. This hugely illustrated textual content presents present and useful info on tested foundational purposes of CMR.

Intracranial Hypertension (Neurology- Laboratory and Clinical Research Developments)

Intracranial high blood pressure (ICH) is the commonest reason for scientific deterioration and dying for neurological and neurosurgical sufferers. there are numerous motives of raised intracranial strain (ICP) and elevated ICP can produce intracranial high blood pressure syndromes. tracking of intracranial strain and advances in investigations of the crucial frightened procedure have ended in new options and systemisations in intracranial high blood pressure.

Individual Differences in Cardiovascular Response to Stress

Demonstrating that the importance and development of cardiovascular reaction to emphasize varies markedly among contributors, this paintings discusses the mechanisms wherein the cardiovascular procedure is mobilized in the course of tension, the determinants of person alterations, and the pathophysiological procedures during which responses to emphasize could lead on to heart problems.

Additional resources for The Year in Interventional Cardiology 2002

Example text

When treatment is started 48 hours prior to cardiac catheterization, tirofiban has been shown to be useful in preventing ischaemic events in patients hospitalized with an acute coronary syndrome who USE OF GLYCOPROTEIN IIB/IIIA INHIBITORS 25 Fig. 3 Incidence of the primary composite end-point (death/non-fatal MI/urgent target vessel revascularization) in the first 30 days after enrolment. 038). Source: Topol et al. (2001). are likely to undergo PCI |15|. However, TARGET would imply that for ‘downstream’ use in the cardiac catheterization laboratory, a standard dose of abciximab is more efficacious than tirofiban at preventing periprocedural ischaemic complications.

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714–19. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330:956–61. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689–96.

Optimal activated clotting time during percutaneous coronary intervention [letter]. Circulation 2001; 104:e83. Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999; 341:319–27. Narins CR, Hillegass WB Jr, Nelson CL, Tcheng JE, Harrington RA, Phillips HR, Stack RS, Califf RM. Relation between activated clotting time during angioplasty and abrupt closure.

Download PDF sample

Rated 4.77 of 5 – based on 7 votes